Clinical Trial Demographics: “[Moderna was] publicizing demographic statistics about the clinical volunteers every week. They're somewhat better than the typical clinical trial but still not a good representation of the diversity of the U.S.”
—BLAKE FARMER, NPR
Regulatory: “In response to ensuing travel restrictions due to the pandemic, FDA is utilizing its authority... to request records in advance of or in lieu of drug inspections, and is also utilizing establishment inspection reports from capable foreign regulatory authorities under the Mutual Recognition Agreement (MRA).”
— DR. STEPHEN HAHN, FDA, SEP. 23 CONGRESSIONAL TESTIMONY
Brand Protection: “In the USA, research earlier this year revealed that almost 70% of consumers have expressed worries about the health crisis driving online sales in counterfeit or sub-standard quality products.”
—INTERNATIONAL HOLOGRAM MANUFACTURERS ASSOCIATION (IHMA)
Making Sense of Reusables: “With reusable packaging, what we're looking to do is to divide any primary manufacturing eco impacts such as CO2, by the number of reuses, so that we deliver a low overall environmental impact. But it's important to be realistic about the number of reuses that will actually be seen from a container and to make sure that it's used more times than the break-even point.”
—MARTIN BLACHER, DIRECTOR OF SUSTAINABILITY AT BOCKATECH
Logistics in a Pandemic: “Airlines are a heavily regulated industry. It’s not easy to mothball an airline and then just restart them again because crews lose their certifications. It would be devastating for transporting the COVID-19 vaccine to lose more airlines.”
